Analysts See $-0.05 EPS for Sangamo Therapeutics, Inc. (SGMO); Profile of 4 Analysts Covering Heritage Financial (HFWA)

April 23, 2018 - By Migdalia James

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Logo

Analysts expect Sangamo Therapeutics, Inc. (NASDAQ:SGMO) to report $-0.05 EPS on May, 9.They anticipate $0.18 EPS change or 78.26% from last quarter’s $-0.23 EPS. After having $-0.15 EPS previously, Sangamo Therapeutics, Inc.’s analysts see -66.67% EPS growth. The stock decreased 6.56% or $1.25 during the last trading session, reaching $17.8. About 1.48 million shares traded. Sangamo Therapeutics, Inc. (NASDAQ:SGMO) has risen 352.38% since April 23, 2017 and is uptrending. It has outperformed by 340.83% the S&P500.

Among 6 analysts covering Heritage Financial (NASDAQ:HFWA), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Heritage Financial had 13 analyst reports since September 28, 2015 according to SRatingsIntel. Sandler O’Neill maintained the shares of HFWA in report on Thursday, January 18 with “Buy” rating. The firm has “Buy” rating given on Monday, March 12 by Keefe Bruyette & Woods. The stock has “Hold” rating by Keefe Bruyette & Woods on Thursday, June 1. The firm has “Hold” rating given on Thursday, December 21 by Keefe Bruyette & Woods. The firm has “Buy” rating given on Friday, January 26 by Sandler O’Neill. The firm earned “Market Perform” rating on Friday, October 23 by Keefe Bruyette & Woods. On Monday, October 5 the stock rating was downgraded by Raymond James to “Mkt Perform”. On Monday, July 10 the stock rating was maintained by Piper Jaffray with “Hold”. The firm has “Buy” rating given on Tuesday, November 7 by DA Davidson. The stock of Heritage Financial Corporation (NASDAQ:HFWA) earned “Outperform” rating by Wood on Monday, March 12. See Heritage Financial Corporation (NASDAQ:HFWA) latest ratings:

12/03/2018 Broker: Keefe Bruyette & Woods Rating: Buy Upgrade
12/03/2018 Broker: Wood Old Rating: Market Perform New Rating: Outperform Upgrade
26/01/2018 Broker: Sandler O’Neill Rating: Buy New Target: $36.0 Maintain
18/01/2018 Broker: Sandler O’Neill Rating: Buy New Target: $35.5 Maintain
21/12/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $33.0 Maintain
07/11/2017 Broker: DA Davidson Rating: Buy Old Target: $35 New Target: $36 Maintain

Since January 2, 2018, it had 0 buys, and 15 sales for $2.56 million activity. Herberts Curt A. III also sold $258,894 worth of Sangamo Therapeutics, Inc. (NASDAQ:SGMO) shares. 9,433 shares were sold by Mento Steven J, worth $219,546 on Thursday, March 1. The insider Conner Edward R. sold 5,000 shares worth $123,878. Shares for $235,080 were sold by Ramasastry Saira. 5,000 Sangamo Therapeutics, Inc. (NASDAQ:SGMO) shares with value of $99,144 were sold by Yi Kathy.

Sangamo Therapeutics, Inc. focuses on translating ground-breaking science into genomic therapies that transform patients' lives using platform technologies in genome editing, gene therapy, gene regulation, and cell therapy. The company has market cap of $1.54 billion. The company's zinc finger DNA-binding protein technology enables specific genome editing and gene regulation. It currently has negative earnings. The ZFPs could be engineered to make ZFP nucleases (ZFNs), proteins that could be used to specifically modify DNA sequences by adding or knocking out specific genes; and ZFP transcription factors (ZFP TFs), proteins that can be used to turn genes on or off.

Among 10 analysts covering Sangamo Biosciences (NASDAQ:SGMO), 7 have Buy rating, 1 Sell and 2 Hold. Therefore 70% are positive. Sangamo Biosciences had 26 analyst reports since August 8, 2015 according to SRatingsIntel. The rating was maintained by Jefferies with “Buy” on Wednesday, September 2. The firm has “Neutral” rating given on Tuesday, November 1 by Wedbush. The stock of Sangamo Therapeutics, Inc. (NASDAQ:SGMO) earned “Buy” rating by Jefferies on Friday, October 23. The firm has “Buy” rating by Jefferies given on Friday, October 13. On Wednesday, October 19 the stock rating was downgraded by Piper Jaffray to “Neutral”. The company was downgraded on Tuesday, September 8 by Zacks. Wedbush maintained Sangamo Therapeutics, Inc. (NASDAQ:SGMO) on Monday, August 14 with “Hold” rating. Jefferies maintained Sangamo Therapeutics, Inc. (NASDAQ:SGMO) on Tuesday, September 12 with “Buy” rating. The rating was maintained by JP Morgan with “Buy” on Thursday, September 3. The company was maintained on Thursday, February 22 by Jefferies.

Investors sentiment decreased to 1.4 in 2017 Q4. Its down 0.17, from 1.57 in 2017Q3. It dived, as 16 investors sold Sangamo Therapeutics, Inc. shares while 42 reduced holdings. 35 funds opened positions while 46 raised stakes. 53.22 million shares or 2.49% more from 51.93 million shares in 2017Q3 were reported. Cornerstone Mgmt Ltd Liability holds 43,200 shares or 0% of its portfolio. Keybank Association Oh owns 37,809 shares for 0% of their portfolio. Los Angeles Capital Mgmt And Equity Inc owns 0% invested in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) for 14,846 shares. 15,497 are held by Comerica Commercial Bank. Manufacturers Life Ins The owns 63,786 shares. Millennium Management Limited Liability Company has invested 0.01% of its portfolio in Sangamo Therapeutics, Inc. (NASDAQ:SGMO). Morgan Stanley invested 0% in Sangamo Therapeutics, Inc. (NASDAQ:SGMO). Prns Limited Com has invested 0.22% in Sangamo Therapeutics, Inc. (NASDAQ:SGMO). Voloridge Invest Mgmt Llc invested in 0.07% or 207,433 shares. Renaissance Technology accumulated 23,800 shares or 0% of the stock. Baldwin Brothers Inc Ma owns 1,500 shares or 0% of their US portfolio. Adage Capital Ptnrs Group Inc Limited Liability owns 2.40M shares for 0.09% of their portfolio. Parametric Assoc Limited Liability Co owns 136,789 shares or 0% of their US portfolio. Pacad Investment Limited holds 0% or 1,300 shares. Beacon Cap Mngmt holds 0% of its portfolio in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) for 4,950 shares.

Heritage Financial Corporation operates as the bank holding firm for Heritage Bank that provides various financial services to small businesses and general public in the United States. The company has market cap of $1.07 billion. The firm accepts various deposit products, such as noninterest demand accounts, NOW accounts, money market accounts, savings accounts, and certificates of deposit. It has a 22.77 P/E ratio. The Company’s loan portfolio includes commercial and industrial loans, owner-occupied and non-owner occupied commercial real estate loans, one-to-four family residential loans, real estate construction and land development loans, consumer loans, business lines of credit, term equipment financing, and term real estate loans, as well as commercial loans real estate related industries and businesses in agricultural, healthcare, legal, and other professions.

Investors sentiment decreased to 1.25 in Q4 2017. Its down 0.07, from 1.32 in 2017Q3. It worsened, as 11 investors sold Heritage Financial Corporation shares while 41 reduced holdings. 20 funds opened positions while 45 raised stakes. 23.54 million shares or 2.62% more from 22.94 million shares in 2017Q3 were reported. Citadel Advsrs Limited Liability stated it has 28,978 shares. Vantage Inv Advsrs Lc stated it has 0.01% of its portfolio in Heritage Financial Corporation (NASDAQ:HFWA). Northwestern Mutual Wealth Management accumulated 66 shares or 0% of the stock. Panagora Asset Mgmt invested 0.02% of its portfolio in Heritage Financial Corporation (NASDAQ:HFWA). 146,332 were reported by Kennedy Capital. The Tennessee-based Martin Company Tn has invested 0.63% in Heritage Financial Corporation (NASDAQ:HFWA). Principal Fin Grp holds 17,666 shares or 0% of its portfolio. Great West Life Assurance Can, Manitoba – Canada-based fund reported 4,962 shares. 130,362 were accumulated by Bridgeway Capital Mgmt Incorporated. Mutual Of America Cap Limited Liability Corp reported 146,886 shares or 0.07% of all its holdings. Banc Funds Limited reported 0.03% stake. 176,863 are owned by Alphaone Investment Limited Liability Corporation. Ny State Common Retirement Fund holds 50,728 shares or 0% of its portfolio. Envestnet Asset Mgmt Inc owns 2,448 shares. Td Asset Mgmt Inc stated it has 25,600 shares or 0% of all its holdings.

Since October 30, 2017, it had 0 insider buys, and 1 sale for $338,360 activity. Shares for $338,360 were sold by PICKERING ANTHONY on Monday, October 30.

The stock increased 1.12% or $0.35 during the last trading session, reaching $31.65. About 44,482 shares traded. Heritage Financial Corporation (NASDAQ:HFWA) has risen 30.89% since April 23, 2017 and is uptrending. It has outperformed by 19.34% the S&P500.

Heritage Financial Corporation (NASDAQ:HFWA) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>